Ending Congenital Syphilis

Irene A. Stafford; Pablo J. Sánchez; Barbara J. Stoll

doi:10.1001/jama.2019.17031

Ending Congenital Syphilis

Irene A. Stafford
, Pablo J. Sánchez
, Barbara J. Stoll

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	2073-2074
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	322
Issue number	21
DOIs	https://doi.org/10.1001/jama.2019.17031
State	Published - Dec 3 2019

Access to Document

10.1001/jama.2019.17031

Cite this

@article{835ae1859cfb4c68945b1e0fe2c49268,

title = "Ending Congenital Syphilis",

author = "Stafford, \{Irene A.\} and S{\'a}nchez, \{Pablo J.\} and Stoll, \{Barbara J.\}",

note = "Funding Information: For many other infections with similar perinatal morbidity and mortality, global and national initiatives have been implemented to educate health care professionals and patients and implement action plans to reduce transmission and burden of disease. After development of the hepatitis B vaccine in 1982, robust national efforts were launched to reduce perinatal transmission. With the support of the federal government, the CDC, and medical organizations, prevention programs based on identification of infected mothers and vaccination of and immunoglobulin administration to newborns successfully reduced hepatitis B transmission rates by more than 90\%.",

year = "2019",

month = dec,

day = "3",

doi = "10.1001/jama.2019.17031",

language = "English",

volume = "322",

pages = "2073--2074",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

number = "21",

}

TY - JOUR

T1 - Ending Congenital Syphilis

AU - Stafford, Irene A.

AU - Sánchez, Pablo J.

AU - Stoll, Barbara J.

N1 - Funding Information: For many other infections with similar perinatal morbidity and mortality, global and national initiatives have been implemented to educate health care professionals and patients and implement action plans to reduce transmission and burden of disease. After development of the hepatitis B vaccine in 1982, robust national efforts were launched to reduce perinatal transmission. With the support of the federal government, the CDC, and medical organizations, prevention programs based on identification of infected mothers and vaccination of and immunoglobulin administration to newborns successfully reduced hepatitis B transmission rates by more than 90%.

PY - 2019/12/3

Y1 - 2019/12/3

UR - https://www.scopus.com/pages/publications/85074954198

U2 - 10.1001/jama.2019.17031

DO - 10.1001/jama.2019.17031

M3 - Comment/debate

C2 - 31710335

AN - SCOPUS:85074954198

SN - 0098-7484

VL - 322

SP - 2073

EP - 2074

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 21

ER -

Ending Congenital Syphilis

Access to Document

Other files and links

Cite this